Ju Fu Tang Biotech Holdings Co., Ltd (HKG:8217)
Hong Kong · Delayed Price · Currency is HKD 0.1160
+0.0080 (7.41%)
Aug 4, 2026, 11:25 AM HKT
HKG:8217 Financials Overview
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 37.56 | 37.56 | 36.2 | 35.14 | 104.6 | 92.75 |
Revenue Growth | 36.49% | 3.74% | 3.02% | -66.41% | 12.77% | -44.89% |
Gross Profit Gross Profit Growth | 1.02 | 1.02 | 0.98 | 1.88 | -2.88 | 1.04 |
Operating Income Operating Income Growth | -6.25 | -6.25 | -11.25 | -4.24 | -12.67 | -21.5 |
Net Income Net Income Growth | 23.32 | 23.32 | -5.9 | -17.43 | -9.96 | -20.15 |
Earnings Per Share EPS Growth | 0.08 | 0.08 | -0.02 | -0.06 | -0.03 | -0.10 |
EPS Growth | 15.20% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Provision of Civil Engineering and Renovation Works Provision of Civil Engineering and Renovation Works Growth | 35.44 | 35.44 | - | - | - | - |
Health Technology Business Health Technology Business Growth | 2.11 | 2.11 | - | - | - | - |
Provision of Civil Engineering Works Provision of Civil Engineering Works Growth | - | - | 36.2 | 35.14 | 104.6 | 92.75 |
Total Total Growth | 37.56 | 37.56 | 36.2 | 35.14 | 104.6 | 92.75 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 60.65 | 60.65 | 30.17 | 26.72 | 44.22 | 44.7 |
Total Debt Total Debt Growth | 12 | 12 | 14.26 | 14.26 | 22.03 | 55.12 |
Net Cash (Debt) Net Cash Growth | 48.65 | 48.65 | 15.91 | 12.45 | 22.18 | -10.42 |
Net Cash Growth | 21.96% | 205.84% | 27.77% | -43.87% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.16 | 0.16 | 0.05 | 0.04 | 0.07 | -0.05 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | - | -7.27 | 3.72 | 32.23 | -19.52 |
Capital Expenditures CapEx Growth | - | - | - | - | - | - |
Free Cash Flow Free Cash Flow Growth | - | - | -7.27 | 3.72 | 32.23 | -19.52 |
Free Cash Flow Growth | - | - | - | -88.45% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 2.71% | 2.71% | 2.71% | 5.35% | -2.75% | 1.12% |
Operating Margin | -16.65% | -16.65% | -31.08% | -12.06% | -12.11% | -23.18% |
Pretax Margin | 62.09% | 62.09% | -16.29% | -49.61% | -9.52% | -21.79% |
Profit Margin | 62.09% | 62.09% | -16.30% | -49.61% | -9.53% | -21.72% |
FCF Margin | - | - | -20.08% | 10.59% | 30.81% | -21.04% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 1.42 | 3.75 | - | - | - | - |
P/FCF Ratio | - | - | - | 7.14 | 1.12 | - |
PS Ratio | 0.87 | 2.33 | 1.74 | 0.76 | 0.35 | 0.54 |